|
FASTK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.220400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.123800E-02 |
| Normal-vs-Stage2 |
6.666100E-02 |
| Normal-vs-Stage3 |
4.958400E-02 |
| Normal-vs-Stage4 |
5.581900E-04 |
| Stage1-vs-Stage2 |
1.859240E-01 |
| Stage1-vs-Stage3 |
5.729600E-01 |
| Stage1-vs-Stage4 |
1.039650E-02 |
| Stage2-vs-Stage3 |
2.767200E-01 |
| Stage2-vs-Stage4 |
8.684600E-01 |
| Stage3-vs-Stage4 |
6.714400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.771900E-02 |
| Normal-vs-AfricanAmerican |
2.03489999999196E-05 |
| Normal-vs-Asian |
2.708600E-01 |
| Caucasian-vs-AfricanAmerican |
2.571200E-04 |
| Caucasian-vs-Asian |
3.042000E-01 |
| AfricanAmerican-vs-Asian |
5.148000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.294400E-02 |
| Normal-vs-Female |
1.161780E-04 |
| Male-vs-Female |
3.109800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.877800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.003900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.384030E-02 |
| Normal-vs-Age(81-100Yrs) |
1.281430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.029800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.512580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.090000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.145000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.173000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.893000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.652400E-02 |
| Normal-vs-Grade 2 |
1.356640E-01 |
| Normal-vs-Grade 3 |
1.816130E-02 |
| Normal-vs-Grade 4 |
1.786560E-04 |
| Grade 1-vs-Grade 2 |
3.229600E-01 |
| Grade 1-vs-Grade 3 |
5.107400E-01 |
| Grade 1-vs-Grade 4 |
2.974800E-01 |
| Grade 2-vs-Grade 3 |
5.387000E-01 |
| Grade 2-vs-Grade 4 |
1.134140E-02 |
| Grade 3-vs-Grade 4 |
1.500150E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.797000E-01 |
| Normal-vs-ccB subtype |
2.149900E-02 |
| ccA subtype-vs-ccB subtype |
4.120300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.815500E-03 |
| Normal-vs-N1 |
2.219700E-03 |
| N0-vs-N1 |
4.703600E-02 |
|
|
